Please try another search
For the fiscal year ended 31 March 2022, Mediclinic International PLC revenues increased 8% to £3.23B. Net income increased from £68M to £151M. Revenues reflect Utilization of Licensed Beds - %-South A increase of 14% to 64.3%. Net income benefited from Share of net loss of equity-accounted in decrease of 99% to £1M (expense), Other Non Operating I/E decrease of 96% to £1M (expense). Dividend per share totaled to £0.03.
Period Ending: | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Total Revenue | 865.5 | 865.5 | 826 | 826 |
Gross Profit | 198 | 198 | 166 | 166 |
Operating Income | 64 | 64 | 73 | 73 |
Net Income | 41.5 | 41.5 | 43 | 43 |
Period Ending: | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Total Assets | 7882 | 7882 | 7207 | 7207 |
Total Liabilities | 4209 | 4209 | 3961 | 3961 |
Total Equity | 3673 | 3673 | 3246 | 3246 |
Period Ending: | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 61.5 | 61.5 | 173.5 | 173.5 |
Cash From Investing Activities | -45.5 | -45.5 | -56 | -56 |
Cash From Financing Activities | -70.5 | -70.5 | -47 | -47 |
Net Change in Cash | -44.5 | -44.5 | 79.5 | 79.5 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review